-
Something wrong with this record ?
Oxycellulose beads with drug exhibiting pH-dependent solubility
M. Bajerová, K. Krejčová, M. Rabišková, J. Muselík, K. Dvořáčková, J. Gajdziok, R. Masteiková
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Free Medical Journals
from 2000 to 2016
PubMed Central
from 2000 to 2016
Europe PubMed Central
from 2000 to 2016
- MeSH
- Anti-Inflammatory Agents, Non-Steroidal chemistry MeSH
- Models, Chemical MeSH
- Diffusion MeSH
- Diclofenac chemistry MeSH
- Chemistry, Pharmaceutical MeSH
- Technology, Pharmaceutical methods MeSH
- Kinetics MeSH
- Hydrogen-Ion Concentration MeSH
- Delayed-Action Preparations MeSH
- Methylcellulose analogs & derivatives chemistry MeSH
- Drug Carriers MeSH
- Drug Compounding MeSH
- Buffers MeSH
- Solubility MeSH
- Spectroscopy, Fourier Transform Infrared MeSH
- Feasibility Studies MeSH
- Particle Size MeSH
- Gastric Juice chemistry MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
The aim of this study was to develop novel hydrogel-based beads and characterize their potential to deliver and release a drug exhibiting pH-dependent solubility into distal parts of gastrointestinal (GI) tract. Oxycellulose beads containing diclofenac sodium as a model drug were prepared by the ionotropic external gelation technique using calcium chloride solution as the cross-linking medium. Resulting beads were characterized in terms of particle shape and size, encapsulation efficacy, swelling ability and in vitro drug release. Also, potential drug-polymer interactions were evaluated using Fourier transform infrared spectroscopy. The particle size was found to be 0.92-0.96 mm for inactive (oxycellulose only) and 1.47-1.60 mm for active (oxycellulose-diclofenac sodium) beads, respectively. In all cases, the sphericity factor was between 0.70 and 0.81 with higher values observed for samples containing higher polymer and drug concentrations. The swelling of inactive beads was found to be strongly influenced by the pH and composition (i.e. Na(+) concentration) of the selected media (simulated gastric fluid vs. phosphate buffer pH 6.8). The encapsulation efficiency of the prepared particles ranged from 58% to 65%. Results of dissolution tests showed that the drug loading inside of the particles influenced the rate of its release. In general, prepared particles were able to release the drug within 12-16 h after a lag time of 4 h. Fickian diffusion was found as the predominant drug release mechanism. Thus, this novel particulate system showed a good potential to deliver drugs specifically to the distal parts of the human GI tract.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12022065
- 003
- CZ-PrNML
- 005
- 20250407150557.0
- 007
- ta
- 008
- 120806s2011 xxuad f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1208/s12249-011-9696-9 $2 doi
- 035 __
- $a (PubMed)22005954
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Kejdušová, Martina. $7 xx0176149 $u Department of Pharmaceutics, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Czech Republic. martina.bajerova@seznam.cz
- 245 10
- $a Oxycellulose beads with drug exhibiting pH-dependent solubility / $c M. Bajerová, K. Krejčová, M. Rabišková, J. Muselík, K. Dvořáčková, J. Gajdziok, R. Masteiková
- 520 9_
- $a The aim of this study was to develop novel hydrogel-based beads and characterize their potential to deliver and release a drug exhibiting pH-dependent solubility into distal parts of gastrointestinal (GI) tract. Oxycellulose beads containing diclofenac sodium as a model drug were prepared by the ionotropic external gelation technique using calcium chloride solution as the cross-linking medium. Resulting beads were characterized in terms of particle shape and size, encapsulation efficacy, swelling ability and in vitro drug release. Also, potential drug-polymer interactions were evaluated using Fourier transform infrared spectroscopy. The particle size was found to be 0.92-0.96 mm for inactive (oxycellulose only) and 1.47-1.60 mm for active (oxycellulose-diclofenac sodium) beads, respectively. In all cases, the sphericity factor was between 0.70 and 0.81 with higher values observed for samples containing higher polymer and drug concentrations. The swelling of inactive beads was found to be strongly influenced by the pH and composition (i.e. Na(+) concentration) of the selected media (simulated gastric fluid vs. phosphate buffer pH 6.8). The encapsulation efficiency of the prepared particles ranged from 58% to 65%. Results of dissolution tests showed that the drug loading inside of the particles influenced the rate of its release. In general, prepared particles were able to release the drug within 12-16 h after a lag time of 4 h. Fickian diffusion was found as the predominant drug release mechanism. Thus, this novel particulate system showed a good potential to deliver drugs specifically to the distal parts of the human GI tract.
- 650 _2
- $a antiflogistika nesteroidní $x chemie $7 D000894
- 650 _2
- $a pufry $7 D002021
- 650 _2
- $a farmaceutická chemie $7 D002626
- 650 _2
- $a léky s prodlouženým účinkem $7 D003692
- 650 _2
- $a diklofenak $x chemie $7 D004008
- 650 _2
- $a difuze $7 D004058
- 650 _2
- $a nosiče léků $7 D004337
- 650 _2
- $a příprava léků $7 D004339
- 650 _2
- $a studie proveditelnosti $7 D005240
- 650 _2
- $a žaludeční šťáva $x chemie $7 D005750
- 650 _2
- $a koncentrace vodíkových iontů $7 D006863
- 650 _2
- $a kinetika $7 D007700
- 650 _2
- $a methylcelulosa $x analogy a deriváty $x chemie $7 D008747
- 650 _2
- $a chemické modely $7 D008956
- 650 _2
- $a velikost částic $7 D010316
- 650 _2
- $a rozpustnost $7 D012995
- 650 _2
- $a spektroskopie infračervená s Fourierovou transformací $7 D017550
- 650 _2
- $a farmaceutická technologie $x metody $7 D013678
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Krejčová, Kateřina. $7 _BN000721 $u Ricesteele Manufacturing Ltd, Tallaght, Ireland
- 700 1_
- $a Rabišková, Miloslava, $d 1951- $7 mzk2005290121 $u Department of Pharmaceutics, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Czech Republic
- 700 1_
- $a Muselík, Jan $7 xx0100243 $u Department of Pharmaceutics, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Czech Republic
- 700 1_
- $a Dvořáčková, Kateřina, $d 1973- $7 xx0138801 $u Department of Pharmaceutics, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Czech Republic
- 700 1_
- $a Gajdziok, Jan $7 xx0126570 $u Department of Pharmaceutics, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Czech Republic
- 700 1_
- $a Masteiková, Ruta, $d 1957- $7 mzk2005317999 $u Department of Pharmaceutics, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Czech Republic
- 773 0_
- $w MED00008281 $t AAPS PharmSciTech $x 1530-9932 $g Roč. 12, č. 4 (2011), s. 1348-1357
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22005954 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m $z 0
- 990 __
- $a 20120806 $b ABA008
- 991 __
- $a 20250407150554 $b ABA008
- 999 __
- $a ok $b bmc $g 943978 $s 779362
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2011 $b 12 $c 4 $d 1348-1357 $e 20111018 $i 1530-9932 $m AAPS PharmSciTech $n AAPS PharmSciTech $x MED00008281
- LZP __
- $b NLK124 $a Pubmed-20120806/12/01/jt